Stocksigma LogoStocksigma Logo

TruAlt Bioenergy Q2 FY27 IPO Proceeds Utilization Report Shows Minimal Deviations

Crisil Ratings reported that TruAlt Bioenergy utilized Rs 741.22 crore of its Rs 750.00 crore gross IPO proceeds as of 30th Sep'26, leaving Rs 8.78 crore

TruAlt Bioenergy Q2 FY27 IPO Proceeds Utilization Report Shows Minimal Deviations

Trualt Bioenergy Ltd 路 Others (Uncategorized) 路 31 Oct 2026, 12:56 am

TruAlt Bioenergy Q2 FY27 IPO Proceeds Utilization Report Shows Minimal Deviations Crisil Ratings reported that TruAlt Bioenergy utilized Rs 741.22 crore of its Rs 750.00 crore gross IPO proceeds as of 30th Sep'26, leaving Rs 8.78 crore unutilized. Net issue proceeds of Rs 657.04 crore saw Rs 656.73 crore deployed, including Rs 425.00 crore for working capital and Rs 81.36 crore for general corporate purposes, both fully utilized by 31st Mar'26. Multi-feedstock capex reached Rs 150.37 crore against Rs 150.68 crore budgeted, with remaining unutilized funds held across monitoring and public offer bank accounts.

Original exchange filing (PDF)

More announcements from Trualt Bioenergy Ltd

All Trualt Bioenergy Ltd announcements